Male Hormonal Contraception.


Journal

Annual review of medicine
ISSN: 1545-326X
Titre abrégé: Annu Rev Med
Pays: United States
ID NLM: 2985151R

Informations de publication

Date de publication:
27 01 2020
Historique:
pubmed: 21 9 2019
medline: 28 11 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

The economic and public health burdens of unplanned pregnancies are evident globally. Since the introduction of the condom >300 years ago, assumptions about male willingness to participate in contraception, as well as concerns about failure rates and side effects, have stagnated the development of additional reversible male contraceptives. However, changing attitudes and recent research advances have generated renewed interest in developing reversible male contraceptives. To achieve effective and reversible suppression of spermatogenesis, male hormonal contraception relies on suppression of testicular testosterone and sperm production using an androgen-progestin combination. While these may be associated with side effects-changes in libido, weight, hematocrit, and cholesterol-recently, novel androgens and progestins have shown promise for a "male pill" with reduced side effects. Here we summarize landmark studies in male contraceptive development, showcase the most recent advances, and look into the future of this field, which has the potential to greatly impact global public health.

Identifiants

pubmed: 31537185
doi: 10.1146/annurev-med-042418-010947
doi:

Substances chimiques

Androgens 0
Contraceptive Agents, Male 0
Progestins 0
Testosterone 3XMK78S47O

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-31

Subventions

Organisme : NICHD NIH HHS
ID : HHSN275201300025I
Pays : United States

Auteurs

Arthi Thirumalai (A)

Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington 98195, USA; email: page@uw.edu.

Stephanie T Page (ST)

Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, Washington 98195, USA; email: page@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH